Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development.

The adenomatous polyposis coli (APC) gene is considered as the true gatekeeper of colonic epithelial proliferation: It is mutated in the majority of colorectal tumors, and mutations occur at early stages of tumor development in mouse and man. These mutant proteins lack most of the seven 20-amino-acid repeats and all SAMP motifs that have been associated with down-regulation of intracellular beta-catenin levels. In addition, they lack the carboxy-terminal domains that bind to DLG, EB1, and microtubulin. APC also appears to be essential in development because homozygosity for mouse Apc mutations invariably results in early embryonic lethality. Here, we describe the generation of a mouse model carrying a targeted mutation at codon 1638 of the mouse Apc gene, Apc1638T, resulting in a truncated Apc protein encompassing three of the seven 20 amino acid repeats and one SAMP motif, but missing all of the carboxy-terminal domains thought to be associated with tumorigenesis. Surprisingly, homozygosity for the Apc1638T mutation is compatible with postnatal life. However, homozygous mutant animals are characterized by growth retardation, a reduced postnatal viability on the B6 genetic background, the absence of preputial glands, and the formation of nipple-associated cysts. Most importantly, Apc1638T/1638T animals that survive to adulthood are tumor free. Although the full complement of Apc1638T is sufficient for proper beta-catenin signaling, dosage reductions of the truncated protein result in increasingly severe defects in beta-catenin regulation. The SAMP motif retained in Apc1638T also appears to be important for this function as shown by analysis of the Apc1572T protein in which its targeted deletion results in a further reduction in the ability of properly controlling beta-catenin/Tcf signaling. These results indicate that the association with DLG, EB1, and microtubulin is less critical for the maintenance of homeostasis by APC than has been suggested previously, and that proper beta-catenin regulation by APC appears to be required for normal embryonic development and tumor suppression.

[1]  B. Mollet,et al.  A Functional Interaction , 2001 .

[2]  D. Pellman,et al.  The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Stagnaro,et al.  Chain‐terminating mutations in the APC gene lead to alterations in APC RNA and protein concentration , 1998, Genes, chromosomes & cancer.

[4]  J. Cooper,et al.  A cytokinesis checkpoint requiring the yeast homologue of an APC-binding protein , 1998, Nature.

[5]  L. Donahue,et al.  A new spontaneous mouse mutation of Hoxd13 with a polyalanine expansion and phenotype similar to human synpolydactyly. , 1998, Human molecular genetics.

[6]  T. Akiyama,et al.  Axin, an inhibitor of the Wnt signalling pathway, interacts with β‐catenin, GSK‐3β and APC and reduces the β‐catenin level , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[7]  Paul Polakis,et al.  Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β , 1998, Current Biology.

[8]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[9]  W. Bodmer,et al.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A Luz,et al.  Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. , 1998, Gastroenterology.

[11]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[12]  T. Akiyama,et al.  Localization of the adenomatous polyposis coli tumour suppressor protein in the mouse central nervous system , 1998, Neuroscience.

[13]  J. Hegemann,et al.  Mal3, the Fission Yeast Homologue of the Human APC-interacting Protein EB-1 Is Required for Microtubule Integrity and the Maintenance of Cell Form , 1997, Journal of Cell Biology.

[14]  A. Markham,et al.  The cellular distribution of the adenomatous polyposis coli tumour suppressor protein in neuroblastoma cells is regulated by microtubule dynamics , 1997, Neuroscience.

[15]  A. Lowy,et al.  Phosphorylation of the Tumor Suppressor Adenomatous Polyposis Coli (APC) by the Cyclin-dependent Kinase p34 cdc2 * , 1997, The Journal of Biological Chemistry.

[16]  M. Pfreundschuh,et al.  RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. , 1997, Journal of immunology.

[17]  K. Makino,et al.  Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein , 1997, Oncogene.

[18]  K. Mostov,et al.  Dynamics of β-Catenin Interactions with APC Protein Regulate Epithelial Tubulogenesis , 1997, The Journal of cell biology.

[19]  P. Polakis.  The adenomatous polyposis coli (APC) tumor suppressor. , 1997, Biochimica et biophysica acta.

[20]  T. Akiyama,et al.  DAP‐1, a novel protein that interacts with the guanylate kinase‐like domains of hDLG and PSD‐95 , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[21]  R. White,et al.  Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[23]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[24]  K. Mostov,et al.  NH2-terminal Deletion of β-Catenin Results in Stable Colocalization of Mutant β-Catenin with Adenomatous Polyposis Coli Protein and Altered MDCK Cell Adhesion , 1997, The Journal of cell biology.

[25]  J. Groden,et al.  Characterization of 19 novel and six recurring APC mutations in Italian adenomatous polyposis patients, using two different mutation detection techniques , 1997 .

[26]  J. Barber,et al.  Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. , 1996, American journal of human genetics.

[27]  Rodney J. Scott,et al.  Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli , 1996, Human Genetics.

[28]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[29]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[30]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. L. Adams,et al.  The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration , 1996, The Journal of cell biology.

[32]  R. Kucherlapati,et al.  Genotype-Phenotype Correlations in Intestinal Carcinogenesis: Lessons From Mouse Models , 1996 .

[33]  T. Akiyama,et al.  Binding of APC to the Human Homolog of the Drosophila Discs Large Tumor Suppressor Protein , 1996, Science.

[34]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[35]  T. Akiyama,et al.  The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. , 1995, The EMBO journal.

[36]  A. Moser,et al.  Homozygosity for the Minallele of Apc results in disruption of mouse development prior to gastrulation , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[37]  R. Brent,et al.  APC binds to the novel protein EB1. , 1995, Cancer research.

[38]  M Oshima,et al.  Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Polakis,et al.  The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. , 1995, The Journal of biological chemistry.

[41]  K. Kinzler,et al.  Inactivation of both APC alleles in human and mouse tumors. , 1994, Cancer research.

[42]  R Fodde,et al.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Polakis,et al.  The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. , 1994, Cancer research.

[44]  T. Pollard,et al.  Wild-type but not mutant APC associates with the microtubule cytoskeleton. , 1994, Cancer research.

[45]  R. Bhat,et al.  High levels of expression of the tumor suppressor gene APC during development of the rat central nervous system , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[47]  F. Masiarz,et al.  Association of the APC gene product with beta-catenin. , 1993, Science.

[48]  G. Joslyn,et al.  Dimer formation by an N-terminal coiled coil in the APC protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Emi,et al.  Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). , 1993, Oncogene.

[50]  K. Kinzler,et al.  Association between wild type and mutant APC gene products. , 1993, Cancer research.

[51]  K. Kinzler,et al.  The APC gene product in normal and tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Yusuke Nakamura,et al.  Mutations of the APC adenomatous polyposis coli) gene , 1993, Human mutation.

[53]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[54]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[55]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[56]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[57]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[58]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[59]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[60]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[61]  G. Cunha.  Hormonal influences on the morphogenesis of the preputial gland of embryonic mice , 1975, The Anatomical Record.

[62]  M. R. Mickey,et al.  Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. , 1973, Journal of the National Cancer Institute.